Accreditation Information

The NCCN 2023 Annual Congress: Hematologic Malignancies™ will focus on updates to the NCCN Guidelines®; new, emerging and novel therapeutic agents; advances in cancer care; and the practical management of patients with hematologic malignancies, including acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia/small lymphocytic lymphoma, classical Hodgkin’s lymphoma, mantle cell lymphoma, and multiple myeloma. Presentations will also address bispecific T-cell engagers, BTK inhibitors, toxicities of CAR T-cell therapy, perioperative management of anticoagulation and antithrombotic therapy, and updates in the WHO/ICC classification system.


Intended Audience
This program is designed to meet the educational needs of physicians, nurse practitioners, nurses, pharmacists, PAs, and other health care professionals who manage patients with hematologic malignancies.


Goal of Education & Overall Congress Objectives
The ultimate goal for NCCN continuing education is to change patient outcomes by improving the competence and performance of clinicians.

The goal of the NCCN 2023 Annual Congress: Hematologic Malignancies™ is to ensure that members of the interprofessional oncology care team, including physicians, nurse practitioners, nurses, PAs, pharmacists, and other relevant health care professionals, have the knowledge and skills necessary to:

  • Apply the current standards of oncology care and key updates in the NCCN Guidelines® to optimize the management of patients with various hematologic malignancies.
  • Review new, emerging, and novel therapeutic agents and treatment strategies and incorporate these into the management of patients with hematologic malignancies.
  • Communicate with members of the interprofessional oncology care team to improve collaborative performance in the management of patients with hematologic malignancies.

Visit the 'Sessions' tab on the left navigation bar for individual session learning objectives.

Accreditation Statements

Joint Accreditation 

Jointly Accredited Provider

In support of improving patient care, National Comprehensive Cancer Network (NCCN) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

   


Physicians 
NCCN designates this live activity for a maximum of 14 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
NCCN designates this educational activity for a maximum of 14 contact hours. This program offers 12 pharmacotherapeutic contact hours for nurses.

Pharmacists
NCCN designates this knowledge-based continuing education activity for 14 contact hours (1.4 CEUs) of continuing education credit. UAN: JA4008196-0000-23-043-L01-P

PAs
NCCN has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 14 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

American Board of Internal Medicine Maintenance of Certification (MOC)

ABIM

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 14 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Aggregated participant data will be shared with the commercial supporters of this activity.

American Board of Pathology Maintenance of Certification (MOC)

ABPath

This activity has been registered to offer credit in the American Board of Pathology’s (ABPath) Maintenance of Certification program. Participants may earn up to 14 Lifelong Learning (Part II) credits.

Aggregated participant data will be shared with the commercial supporters of this activity.

 

American Board of Medical Specialties Maintenance of Certification (MOC)

Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, NCCN 2023 Annual Congress: Hematologic Malignancies has met the requirements as a Lifelong Learning CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:

ABMS Lifelong Learning CME Activity

  • Radiology

How to Claim Credit

Credit claiming is open now. Please click on the 'How to Claim Credit' tab on the left navigation bar for more information.

If you have questions, please email education@nccn.org.